Prominent USC Geneticist Sentenced to 14 Years for Molesting Girl_AP
In sentencing William French Anderson, the judge said: "Because of intellectual arrogance, he persisted and he got away with as much as he could."
In sentencing William French Anderson, the judge said: "Because of intellectual arrogance, he persisted and he got away with as much as he could."
The journal, Nature, reports that the American Association of Publishers (AAP) has hired Eric Dezenhall to fight against open access scientific articles.
In essence FDA proposals merely change the seating arrangement on the deck of the sinking Titanic. Eli Lilly announced that it intends to seek FDA approval for a long-lasting injectable form of Zyprexa (taken once a month).
Merck is lobbying states to MANDATE schoolgirls to be vaccinated with its new vaccine.
An appalling spectacle is taking place in secret in the U.K. whose stench is reminiscent of the Salem witches trials of 1692!
The first in the BBC-Panorama series elicited more than 65,000 emails and phone calls.The fourth report aired tonight, focuses on study #329, the largest of the Paxil pediatric trials. BBC will show evidence of how the published report of this trial was manipulated to deceive physicians about the safety and efficacy findings. [see Friday's Infomail…
Read: Transcript of Hearing Re: RE: ZYPREXA LITIGATION, MDL 04 1596 in U.S.
District Court Eastern District of NEW YORK
BBC-Panorama–third in a series: The Secrets of Seroxat. "In the interests of patients and professional integrity" is to show those who have sold their reputations "intolerance and exposure."
"Daily use of SSRIs was also associated with a four per cent reduction in bone mineral density of the hip and 2.4 per cent of the lower spine, the study found."
The FDA is salivating in expectation of increased funding from the drug industry–ostensibly to speed up the reviewing process for TV ads.
Documents uncovered during the course of litigation shed light on real risks of drug-induced harm that would not otherwise be known.
The authors argue that recommendations for the expanded use of statins to stave off cardiovascular disease are NOT supported by the evidence.